C-Care (Mauritius) Ltd and Healthcare Global Enterprises (HCG) have entered into a partnership to offer cancer treatment in Mauritius. Under the agreement, HCG will offer clinical and outpatient consultation services at the C-Care Cancer Center. HCG doctors specializing in oncology will facilitate these services, ensuring access to modern cancer care.

The partnership focuses on five key areas: clinical services, training and knowledge-sharing, modern diagnostic services, patient referrals, and excellence. HCG will provide oncologists to ensure access to advanced cancer care. C-Care’s nuclear medicine staff will receive training from HCG experts to enhance their skills and knowledge. Patients can be referred to HCG for PET scans at preferential rates.

The agreement guarantees patient follow-up and continuity of care. With C-Care having obtained all necessary government approvals, both organizations can ensure seamless delivery of HCG’s services. As a result of this partnership, Mauritian patients are expected to benefit from personalized treatments and international expertise they get access to.

Raj Gore, CEO of HCG, said, “This MoU represents a shared vision of improving cancer care and making it more accessible to patients in the region.”

Hélène Echevin, CEO of C-Care Group, said, “This collaboration will improve the quality of cancer care available in Mauritius and ensure that our patients have access to the best possible treatment options.”